Plexus Corp. (NASDAQ:PLXS – Get Free Report) insider Michael Running sold 926 shares of Plexus stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $204.92, for a total transaction of $189,755.92. Following the completion of the transaction, the insider owned 1,295 shares in the company, valued at approximately $265,371.40. This represents a 41.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link.
Plexus Price Performance
Shares of PLXS opened at $196.28 on Thursday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.75 and a current ratio of 1.59. Plexus Corp. has a fifty-two week low of $103.43 and a fifty-two week high of $208.92. The firm has a 50-day simple moving average of $163.58 and a 200-day simple moving average of $147.30. The company has a market capitalization of $5.25 billion, a price-to-earnings ratio of 30.53 and a beta of 0.81.
Plexus (NASDAQ:PLXS – Get Free Report) last issued its quarterly earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.77 by $0.01. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The firm had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.07 billion. During the same quarter in the previous year, the firm posted $1.73 EPS. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. On average, equities research analysts anticipate that Plexus Corp. will post 5.9 earnings per share for the current year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
A number of equities analysts have commented on PLXS shares. Needham & Company LLC upped their price objective on shares of Plexus from $165.00 to $206.00 and gave the stock a “buy” rating in a research report on Friday, January 30th. Williams Trading set a $195.00 price target on shares of Plexus in a report on Wednesday, January 28th. Wall Street Zen downgraded shares of Plexus from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Stifel Nicolaus boosted their target price on Plexus from $150.00 to $200.00 and gave the stock a “hold” rating in a research report on Friday, January 30th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Plexus in a report on Thursday, January 22nd. Two investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $189.20.
Get Our Latest Report on Plexus
Plexus News Roundup
Here are the key news stories impacting Plexus this week:
- Positive Sentiment: Analysts have raised Plexus’ price targets (one report notes a 26.29% increase to $204.82), which supports upside relative to prior targets. Article Title
- Positive Sentiment: Several broker reports (Benchmark, Stifel, Williams Trading) have lifted price objectives or reiterated coverage, keeping Street sentiment constructive overall. MarketBeat PLXS Coverage
- Positive Sentiment: Major institutional holders reported increases in positions (e.g., Massachusetts Financial Services, Wedge Capital), indicating continued institutional interest beneath the surface. Institutional Holdings
- Neutral Sentiment: Latest quarterly results showed a very slight EPS beat (reported $1.78 vs. $1.77 estimate) and revenue essentially in line; management guided Q2 to $1.80–$1.95 EPS — generally stable but not a clear catalyst. Earnings & Guidance
- Negative Sentiment: CEO Todd P. Kelsey sold 8,120 shares at ~$205.65 (≈$1.67M), a ~9.4% reduction in his holdings — a sizable insider sale that can spook investors. CEO Form 4
- Negative Sentiment: CFO Patrick J. Jermain sold 4,841 shares at ~$204.01 (~$988k), a ~19% reduction in his stake — another senior-management sell. CFO Form 4
- Negative Sentiment: Chairman Dean A. Foate sold 5,000 shares at ~$204.89 (~$1.02M), trimming his position by 25% — adds to the cluster of insider liquidity. Chairman Form 4
- Negative Sentiment: Other insiders (e.g., Michael J. Running) also reported smaller sales, amplifying the market’s interpretation that executives are taking profits near recent highs. Insider Sale Filing
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Recommended Stories
- Five stocks we like better than Plexus
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Trump Planning to Use Public Law 63-43: Prepare Now
- Forget AI, This Will Be the Next Big Tech Breakthrough
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
